Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
ACCELERON PHARMA INC (XLRN) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/08/2018 BW Acceleron Reports First Quarter 2018 Operating and Financial Results
04/30/2018 BW Acceleron to Webcast First Quarter 2018 Operating and Financial Results on May 8, 2018
02/27/2018 BW Acceleron Reports Fourth Quarter and Full Year 2017 Operating and Financial Results
02/20/2018 BW Acceleron to Webcast Fourth Quarter and Full Year 2017 Operating and Financial Results on February 27, 2018
01/02/2018 BW Acceleron to Webcast Presentation at the 36th Annual J.P. Morgan Healthcare Conference
12/10/2017 BW Acceleron Announces Updated Results from Ongoing Phase 2 Trials of Luspatercept in Myelodysplastic Syndromes at the 59th Annual Meeting of the American Society of Hematology
12/05/2017 BW Acceleron to Host Conference Call and Webcast to Review Data Presented at the 59th American Society of Hematology Annual Meeting and Exposition
11/07/2017 BW Acceleron Pharma Reports Third Quarter 2017 Operational and Financial Results
10/26/2017 BW Acceleron to Webcast Third Quarter 2017 Financial Results on November 7, 2017
09/19/2017 BW Acceleron to Develop Sotatercept in Pulmonary Arterial Hypertension
09/12/2017 BW Acceleron to Host Research and Development Day on September 19, 2017
08/03/2017 BW Acceleron Pharma Reports Second Quarter 2017 Operational and Financial Results
07/27/2017 BW Acceleron to Webcast Second Quarter 2017 Financial Results on August 3, 2017
05/08/2017 BW Acceleron Pharma Reports First Quarter 2017 Operational and Financial Results
05/06/2017 BW Luspatercept Phase 2 Data Presented at the 14th International Symposium on Myelodysplastic Syndromes
05/01/2017 BW Acceleron to Participate in Two Healthcare Investor Conferences in May
04/26/2017 BW Acceleron to Host Webcast to Review First Quarter 2017 Financial and Operational Results on May 8, 2017
03/16/2017 BW Acceleron Announces Plans to Initiate a Phase 2 Trial of ACE-083 in Charcot-Marie-Tooth Neuromuscular Disease and Host Educational Webinar
03/01/2017 BW Acceleron Reports Fourth Quarter and Year Ended 2016 Operational and Financial Results
02/22/2017 BW Acceleron Pharma to Webcast Conference Call of Fourth Quarter and Year Ended 2016 Financial Results on March 1, 2017
02/01/2017 BW Acceleron to Participate in Two Healthcare Investor Conferences in February

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy